ANN ARBOR MIMarketwired February 26 2015 Esperion Therapeutics Inc. NASDAQ ESPR an emerging pharmaceutical company focused on developing and commercializing firstinclass oral lowdensity lipoprotein cholesterol LDLcholesterol lowering therapies for the tr...
↧